High Tower Advisors, LLC Bristol Myers Squibb CO Call Options Transaction History

High Tower Advisors, LLC

5 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2024 May 06, 2024	BUY	$47.98 - $54.4 $9,596 - $10,880	200 New	200 $10,000
Q4 2019 Feb 14, 2020	SELL	$49.21 - $64.19 $590,520 - $770,280	-12,000 Reduced 80.0%	3,000 $14,000
Q4 2017 Feb 14, 2018	BUY	$59.94 - $65.35 $125,874 - $137,235	2,100 Added 16.28%	15,000 $2,000
Q3 2017 Nov 14, 2017	BUY	$55.23 - $63.74 $463,932 - $535,416	8,400 Added 186.67%	12,900 $50,000
Q2 2017 Aug 14, 2017	BUY	N/A	4,500	4,500 $13,000

2,428

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of High Tower Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on High Tower Advisors, LLC with notifications on news.